Emergent BioSolutions

Emergent BioSolutions Inc. is a multinational specialty biopharmaceutical company based in Gaithersburg, Maryland. Founded in 1998, the company focuses on developing vaccines, antibody therapeutics, and medical devices aimed at combating infectious diseases, opioid overdoses, and biodefense threats. One of its cornerstone products is BioThrax®, the only FDA-licensed anthrax vaccine, which is primarily used by U.S. military and government agencies. The company offers a range of products, including NARCAN® Nasal Spray, an emergency treatment for opioid overdoses, and various vaccines and therapeutics for diseases such as cholera, typhoid, and Ebola. Emergent also provides contract development and manufacturing services, including the production of COVID-19 vaccines for major pharmaceutical companies. Its services encompass the development of medical countermeasures for various threats and emergency preparedness solutions. Emergent BioSolutions serves a diverse customer base, including U.S. government agencies, community organizations, and international public health agencies, reflecting its commitment to public health defense and emergency medical preparedness.